Evaluating Remote Monitoring for Cancer Patients Using the Caaring Mobile App During Outpatient Oral Treatment

What this Trial Is About

Researchers are evaluating the effectiveness of a remote monitoring software called Caaring in cancer patients undergoing outpatient oral cancer treatment. The study aims to see if using this self-management platform helps patients manage their illness better and reduces the number of in-person and telephone visits with specialized medical and nursing staff. This is a randomized, multicenter clinical trial comparing two groups of patients over 12 weeks. One group will use the Caaring app on their smartphones to report data and complete questionnaires related to their treatment and health. This group will also receive educational and prevention recommendations about cancer. The other group will receive routine medical follow-up visits without the remote monitoring app. Both groups will be observed for 12 weeks following their inclusion in the study. Participants will be monitored through the app or routine visits, with researchers collecting information on treatment adherence, completion of data, use of health resources, and patient satisfaction with the software. The main outcome is the percentage of adherence to prescribed treatment over 12 weeks. Secondary outcomes include data completion rates, changes in health resource use, and patient satisfaction. The study involves regular assessments and questionnaires, with a total participation duration of 12 weeks.

Determining the Effectiveness of Remote Monitoring of Cancer Patients With Oral Cancer Treatment Using Caaring® Software